Abstract
L Stobbart and colleagues examine newspaper coverage of adverse events in the TGN1412 trial
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal, Humanized
-
Clinical Trials, Phase I as Topic
-
Human Experimentation / standards*
-
Humans
-
Newspapers as Topic*
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
TGN-1412